Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Pediatr Endocrinol Metab. 2013;26(1-2):183-5. doi: 10.1515/jpem-2012-0372.

Hepatitis in an infant treated with octreotide for congenital hyperinsulinism.

Author information

  • 1Armon Child Center, Haifa, Israel. ilanaza2@clalit.org.il

Abstract

Congenital hyperinsulinism is characterized by hypoglycemia caused by several genetic disorders of inappropriate insulin secretion. Octreotide, an analogue of somatostatin, plays a major role in the pharmaceutical treatment of this condition. A 9-month-old infant treated with octreotide developed anicteric hepatitis with no other proven cause. After the discontinuation of this drug, the liver enzymes declined rapidly. Liver function tests should be followed in patients receiving octreotide.

PMID:
23327817
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for iFactory
    Loading ...
    Write to the Help Desk